global cancer therapeutics and biotherapeutics market cover

Cancer Therapeutics and Biotherapeutics Market

Segments - by Technology (Chemotherapy, Radiation Therapy, Hormone Therapy, and Biotherapy) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2545
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 47
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global cancer therapeutics and biotherapeutics market size is expected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rise in cancer incidence along with increase in cancer research and collaboration among pharmaceutical companies.

global cancer therapeutics and biotherapeutics market summary

Cancer disease includes the abnormal growth of cells that primarily cause the formation of a tumor. As per several global health reports, cancer frequency has been growing progressively over the past half-century due to changing lifestyle especially increasing number of smokers. Growing number of patients for greater life longevity is influenced due to improved diagnostic devices and bio-therapeutic products. In most developed countries, the first- or second-leading cause of death is cancer while in developing or underdeveloped countries it is gradually increasing its ranking in terms of a factor for high mortality rate. According to the Globocan 2020 fact sheet, 19.3 million new cancer cases were diagnosed worldwide, with nearly 10 million deaths due to cancers. Furthermore, according to evaluations from the International Agency for Research on Cancer (IARC), by 2040, the global cases of cancers is expected to rise to 27.5 million new cancer cases and 16.3 million deaths globally. The World Health Organization (WHO) also estimates that the new cancer cases is going to rise from 18 million in 2018 to 29.4 million by 2040.These factors suggest the cancer therapy market is expected to witness tremendous growth.

Among the latest developments, biotherapy is the novel method for treatment of cancer as it stimulates the natural tendency of the body to battle with the cancerous cells leaving the healthy tissues of the body unaffected. This new therapy is gaining popularity in the population due to its less side-effects as well as new product approvals.

Market Trends, Drivers, Restraints, and Opportunities

  • Governments’ favorable initiatives for the cancer treatment and prevention along with rising awareness campaigns are key factors driving the market growth.
  • New product approvals along with high number of research and development activities with participation of major players is boosting the market growth.
  • High funding and investments by the market players as well as government and non-government organization are propelling the market growth.
  • High cost associated with the drugs used for cancer treatment coupled with severe adverse effects are major restraining factors that can hinder the market expansion in the coming years.
  • Rising preference of personalized medicine along with growth of developing countries and high cancer prevalence are presenting huge opportunities for the market in the near future.

Scope of the Report

The report on the global cancer therapeutics and biotherapeutics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Cancer Therapeutics and Biotherapeutics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Technology (Chemotherapy, Radiation Therapy, Hormone Therapy, and Biotherapy)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Bristol-Myers Squibb; AstraZeneca PLC; Pfizer Inc.; Biogen IDEC, Company; Sanofi; Genentech; Eli Lilly & Company; Merck & Company Inc.; Novartis AG; Johnson & Johnson; Roche; and Schering-Plough.

Market Segment Insights

Chemotherapy segment is expected to grow at a rapid pace

Based on technology, the global cancer therapeutics and biotherapeutics market is divided into chemotherapy, radiation therapy, hormone therapy, and biotherapy. The chemotherapy segment is expected to grow at a rapid pace during the forecast period owing to the high cancer prevalence and better results than rest of the therapies available. The chemotherapy is a combination of drugs for the treatment of cancer. The drugs category used for the combination includes cytotoxic agents, alkylating agents, plant derivatives, antimetabolites, and others.

global cancer therapeutics and biotherapeutics market type

On the other hand, the radiation therapy segment is anticipated to grow substantially in the coming years since the therapy involves the use of ionizing radiation to kill or control the cancer cells. Some of common types of radiation therapy widely used for the cancer treatment are intraoperative radiotherapy, radioisotope therapy, external beam radiation therapy, and brachytherapy. Meanwhile, the hormone therapy is projected to exhibit a high CAGR during the forecast period owing to extensive use of the therapy method as several patients require hormones administered into the body for controlling endocrine system. It functions as antagonist of the hormones by inhibiting the production of such hormones. Major therapies of this type of method includes the use of corticosteroids, selective estrogen receptor modulators (SERMs), hormone antagonists or antagonists, and aromatase inhibitors.

The biotherapeutics segment, however, is expected to represent a considerable market share during the projected period as the type of therapy involves the use of living organism to extract the drugs for the treatment of diseases such as, sclerosis, rheumatoid arthritis, cancer, and others. The therapy works on the principle of improving natural immunity of the body or to restore it to kill or control the cancer cells. It includes the use of monoclonal kinases, antibodies, interferon or interleukins, and others.

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period owing to the high cancer prevalence, government favorable policies, advanced research, as well as advanced healthcare facility in the region. Moreover, large number of skilled professionals, rapid diagnosis techniques availability, and presence of advanced technologies are driving the market in the region.

global cancer therapeutics and biotherapeutics market region

The Asia Pacific market, however, is anticipated to exhibit substantial growth due to the high cancer patients and advancement in healthcare facilities in the region. Additionally, high awareness among the population, governments’ active participation, and increasing economic development are propelling the regional market expansion.

Segments

The global cancer therapeutics and biotherapeutics market has been segmented on the basis of

Technology

  • Chemotherapy
  • Radiation Therapy
  • Hormone Therapy
  • Biotherapy

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Sanofi
  • Bristol-Myers Squibb
  • Pfizer Inc.
  • Biogen IDEC, Company
  • Eli Lilly & Company
  • AstraZeneca PLC
  • Merck & Company Inc.
  • Novartis AG
  • Johnson & Johnson
  • Genentech
  • Roche
  • Schering-Plough.

Competitive Landscape

The key players of the global cancer therapeutics and biotherapeutics market are Sanofi; Bristol-Myers Squibb; Pfizer Inc.; Biogen IDEC, Company; Eli Lilly & Company; AstraZeneca PLC; Merck & Company Inc.; Novartis AG; Johnson & Johnson; Genentech; Roche; and Schering-Plough.

global cancer therapeutics and biotherapeutics market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. cancer therapeutics and biotherapeutics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. cancer therapeutics and biotherapeutics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. cancer therapeutics and biotherapeutics Market - Supply Chain
  4.5. Global cancer therapeutics and biotherapeutics Market Forecast
     4.5.1. cancer therapeutics and biotherapeutics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. cancer therapeutics and biotherapeutics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. cancer therapeutics and biotherapeutics Market Absolute $ Opportunity
5. Global cancer therapeutics and biotherapeutics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. cancer therapeutics and biotherapeutics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global cancer therapeutics and biotherapeutics Demand Share Forecast, 2019-2026
6. North America cancer therapeutics and biotherapeutics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America cancer therapeutics and biotherapeutics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America cancer therapeutics and biotherapeutics Demand Share Forecast, 2019-2026
7. Latin America cancer therapeutics and biotherapeutics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America cancer therapeutics and biotherapeutics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America cancer therapeutics and biotherapeutics Demand Share Forecast, 2019-2026
8. Europe cancer therapeutics and biotherapeutics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe cancer therapeutics and biotherapeutics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe cancer therapeutics and biotherapeutics Demand Share Forecast, 2019-2026
9. Asia Pacific cancer therapeutics and biotherapeutics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific cancer therapeutics and biotherapeutics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific cancer therapeutics and biotherapeutics Demand Share Forecast, 2019-2026
10. Middle East & Africa cancer therapeutics and biotherapeutics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa cancer therapeutics and biotherapeutics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa cancer therapeutics and biotherapeutics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global cancer therapeutics and biotherapeutics Market: Market Share Analysis
  11.2. cancer therapeutics and biotherapeutics Distributors and Customers
  11.3. cancer therapeutics and biotherapeutics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Sanofi
     11.4.2. Bristol-Myers Squibb
     11.4.3. Pfizer Inc.
     11.4.4. Biogen IDEC, Company
     11.4.5. Eli Lilly & Company
     11.4.6. AstraZeneca PLC
     11.4.7. Merck & Company Inc.
     11.4.8. Novartis

Buy Report